Microneedle based targeted allergen specific immunotherapy for treatment of peanut allergies

Ended Project Grant Awarded Last action

Award ID
R42AI143011
Recipient
Awarding agency
Obligated
$5,292,092

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $4,357,670.00 Federal
  • $934,422.00 Non-federal
Place of performance
Georgia, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $918,854 $0
Amendment $918,854 $0
Amendment -$54,575 $0
Amendment -$55,000 $0
Amendment $109,575 $0
Amendment -$54,575 $0
Amendment -$55,000 $0
Amendment $109,575 $0
Amendment -$55,000 $0
Amendment -$54,575 $0
Amendment $109,575 $0
Amendment $934,422 $0
Amendment $934,422 $934,422
Amendment $55,000 $0
Amendment $297,759 $0
Original award $298,359 $0
Show all 17

Quick answers

Who received award R42AI143011?

R42AI143011 was awarded to Moonlight Therapeutics, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 1, 2019.

How much is award R42AI143011 worth?

$5,292,092 has been obligated on R42AI143011: $4,357,670 in federal funding and $934,422 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award